1[1]Naccarelli G V, Lee K S, Gibson J K, et al. Electrop hysiology and pharmacology of ibutilide. Am J Cardiol, 1996, 78(8A): 12-16.
2[2]Oshikawa N, Watanabe I, Masaki R, et al. Frequency-dependent electroph ysiological effect of ibutilide on human atrium and ventricle. J Interv Card Ele ctrophysiol, 2001, 5(1): 81-87.
3[3]Lee K S, Lee E W. Ionic mechanism of ibutilide in human atrium: Evidenc e for a drug-induced Na+ current through a nifedipine inhibited inward channe l. J Pharmacol Exp Ther, 1998, 286(1): 9-22.
4[4]Ellenbogen K A, Stambler B S, Wood M A, et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dos e-response study. J Am Coll Cardiol, 1996, 28: 130-136.
5[5]Stambler B S, Wood M A, Ellenbogen K A, et al. Efficacy and safety of r epeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation, 1996, 94: 1613-1621.
6[6]Murray K T. Ibutilide. Circulation, 1998, 97: 493-497.
7[7]Stambler B S, Wood M A, Ellenbogen K A. Antiarrhythmic actions of intra venous ibutilide compared with procainamide during human atrial flutter and fibr illation: Electrophysiological determinants of enhanced coversion efficacy. Circ ulation, 1997, 96(12): 4298-4306.
8[8]Pitzalis M V, Grimaldi M, Anaclerio M, et al. Usefulness of handgrip to improve ibutilide efficacy in organizing atrial electrical activity during atri al fibrillation. Am J Cardiol, 2001, 87(6): 798-801, A8-9.
9[9]Schwartz R A, Langberg J J. Atrial electrophysiological effects of ibut ilide infusion in human. Pacing Clin Electrophysiol, 2000, 23(5): 832-836.
10[10]Buchanan L V, LeMay R J, Walters R R, et al. Antiarrhythmic and electr ophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model. J Cardiovasc Electrophysiol, 1996, 7: 113-119.
